• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Tri Teva
    / SLE

    Active Ingredient *

    Status in Israel

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft



    not in the basket chart


    Adults: The recommended dose is one tablet taken orally once daily. The tablet should be swallowed whole, on empty stomach not crushed, chewed or halved.
    Please refer to the license holder for further details.


    Indicated for use alone as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults.


    Hypersensitivity to an active substance or to any of its excipients.
    Patients with severe liver disease.
    Patients with cardiac disorders e.g.: QT prolongation, Torsades de Pointes.
    Patient with family history of cardiac disorders.
    Patients with hypokalemia, hypomagnesemia.
    Concomitant use with astemizole,  terfenadine− bepridil, cisapride elbasvir/grazoprevir,  ergot alkaloids (e.g. ergotamine, dihydroergotamine, ergonovine and methylergonovine) midazolam or triazolam, pimozide, imipramine, amitriptyline or clomipramine, hypericum perforatum (st. john’s wort) voriconazole, flecainide, metoprolol, macrolides, fluoroquinolones, imidazole, anti-fungal triazole, certain anti-malarial medicines, methadone.

    Teva Pharmaceutical Industries Ltd, Israel
    Licence holder